<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Friday September 29th 2017 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2017-09-29" ></link>
<id>urn:uuid:0635db86-2963-5fb4-9a57-678a25aed9ad</id>
<updated>2026-07-25T12:15:31-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ACM: BURKE MICHAEL S (CB,CEO,DIR) Sold (AS) 30k Shares of AECOM for $37.00 on 9/27</title>
<link href="http://www.insiderinsights.com/company/acm/aecom/id-3418689" ></link>
<id>urn:uuid:396ea212-db3f-2766-7aea-029a87fc2fe4</id>
<updated>2017-09-29T19:54:26-04:00</updated>
<summary type="html" ><![CDATA[AECOM (ACM)]]></summary>
</entry>
<entry>
<title>ARRY: VAN LUNSEN GIL J (DIR) Exercised 45k Options (OE*) of ARRAY BIOPHARMA INC for $10.58 on 9/29, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/arry/array-biopharma-inc/id-3418618" ></link>
<id>urn:uuid:0e040c62-2518-4ef5-cb59-9ea2e42ad02d</id>
<updated>2017-09-29T18:23:07-04:00</updated>
<summary type="html" ><![CDATA[ARRAY BIOPHARMA INC (ARRY). Recent Price: $5.32. Mkt Cap:818.4mm. 10D Vol: 6.7mm]]></summary>
</entry>
<entry>
<title>ARRY: LEFKOFF KYLE (DIR) Exercised 45k Options (OE*) of ARRAY BIOPHARMA INC for $10.58 on 9/29, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/arry/array-biopharma-inc/id-3418620" ></link>
<id>urn:uuid:926c5baa-d5cd-32d5-f54b-f5591de857dc</id>
<updated>2017-09-29T18:22:42-04:00</updated>
<summary type="html" ><![CDATA[ARRAY BIOPHARMA INC (ARRY). Recent Price: $5.32. Mkt Cap:818.4mm. 10D Vol: 6.7mm]]></summary>
</entry>
<entry>
<title>BOLD: ORBIMED ADVISORS LLC (BO) Sold (JS*) 672k Shares of AUDENTES THERAPEUTICS INC for $28.25 on 9/29</title>
<link href="http://www.insiderinsights.com/company/bold/audentes-therapeutics-inc/id-3418615" ></link>
<id>urn:uuid:fdf6820f-a9be-0bdf-2752-e48909bc4b03</id>
<updated>2017-09-29T18:06:57-04:00</updated>
<summary type="html" ><![CDATA[AUDENTES THERAPEUTICS INC (BOLD). Recent Price: $2.57. Mkt Cap:57.8mm. 10D Vol: 204,540]]></summary>
</entry>
<entry>
<title>AUBN: ANDRUS TERRY W (DIR) Bought (JB*) 34 Shares of AUBURN NATIONAL BANCORPORATION INC for $36.34 on 9/28</title>
<link href="http://www.insiderinsights.com/company/aubn/auburn-national-bancorporation-inc/id-3418596" ></link>
<id>urn:uuid:d6d839b0-ae54-a7c8-4a9d-934936e24d8e</id>
<updated>2017-09-29T17:53:02-04:00</updated>
<summary type="html" ><![CDATA[AUBURN NATIONAL BANCORPORATION INC (AUBN). Recent Price: $26.62. Mkt Cap:93.0mm. 10D Vol: 1,310]]></summary>
</entry>
<entry>
<title>BOLD: NAGLER DAVID (VP,HR) Exercised 3,750 Options (OE) of AUDENTES THERAPEUTICS INC for $2.19 on 9/27, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/bold/audentes-therapeutics-inc/id-3418586" ></link>
<id>urn:uuid:4bb4a138-9821-0c50-ea3c-a59b13048c33</id>
<updated>2017-09-29T17:48:02-04:00</updated>
<summary type="html" ><![CDATA[AUDENTES THERAPEUTICS INC (BOLD). Recent Price: $2.57. Mkt Cap:57.8mm. 10D Vol: 204,540]]></summary>
</entry>
<entry>
<title>BOLD: LANGE LOUIS G (DIR) Sold (S) 5k Shares of AUDENTES THERAPEUTICS INC for $28.31-$29.32 on 9/29</title>
<link href="http://www.insiderinsights.com/company/bold/audentes-therapeutics-inc/id-3418588" ></link>
<id>urn:uuid:e7aa1d1c-8607-1bde-9e4a-5a5e20ca05d4</id>
<updated>2017-09-29T17:47:10-04:00</updated>
<summary type="html" ><![CDATA[AUDENTES THERAPEUTICS INC (BOLD). Recent Price: $2.57. Mkt Cap:57.8mm. 10D Vol: 204,540]]></summary>
</entry>
</feed>